New COVID-19 drug used to treat patients suffering from respiratory failure is in trials

Fox Business

Apr. 07, 2021 – 5:06 – NeuroRX CEO Dr. Jonathan Javitt discusses the new COVID-19 drug for respiratory distress and vaccine boosters.